Concepedia

Author

R. Babic

Ludwig-Maximilians-Universität München

Also Known As

R BABIC, R Babic, R. BABIC, R. Babic, RUDOLF BABIC, Rudolf Babic

48

Publications

1.9K

Citations

20

H-Index

47

Concepts

All Affiliations

Ludwig-Maximilians-Universität MünchenDeggendorf Institute of TechnologyDeutsches Herzzentrum der CharitéInstitute of Cytology
RB

About

R. Babic is an author at Ludwig-Maximilians-Universität München specializing in medicine, pathology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

869

2

Health Sciences

2

2

57

3

Engineering

1

1

31

4

Public Health

1

1

114

5

Biomedical Engineering

1

1

31

R. Babic

×

24

Publications

1.9K

Citations

20

H-Index

YearCitations

c-erbB-2 Is of Independent Prognostic Relevance in Gastric Cancer and Is Associated With the Expression of Tumor-Associated Protease Systems

Heike Allgayer, R. Babic, Klaus Uwe Gruetzner,

Journal of Clinical Oncology

2000

279

Individual development and uPA–receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer

M. M. Heiss, Heike Allgayer, Klaus Uwe Gruetzner,

Nature Medicine

1995

251

Prognostic significance of bone marrow micrometastases in patients with gastric cancer.

K.-W. Jauch, M. M. Heiss, Uwe Gruetzner,

Journal of Clinical Oncology

1996

192

Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer

F. Jänicke, Manfred Schmitt, R. Hafter,

Fibrinolysis and Proteolysis

1990

183

Competition of coronary arteries and ventriculo-coronary arterial communications in pulmonary atresia with intact ventricular septum

Adriana C. Gittenberger–de Groot, Ursula Sauer, L. Bindl,

International Journal of Cardiology

1988

114

Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system.

M. M. Heiss, R. Babic, Heike Allgayer,

Journal of Clinical Oncology

1995

114

Minimal Residual Disease in Gastric Cancer: Evidence of an Independent Prognostic Relevance of Urokinase Receptor Expression by Disseminated Tumor Cells in the Bone Marrow

M. M. Heiss, Erich Simon, B. C. M. Beyer,

Journal of Clinical Oncology

2002

75

Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease.

Heike Allgayer, M. M. Heiss, Rainer Riesenberg,

PubMed

1997

73

Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns

Heike Allgayer, R. Babic, Klaus Uwe Gr tzner,

Clinical & Experimental Metastasis

1998

71

Coronary arteries in the hypoplastic left heart syndrome. Histopathologic and histometrical studies and implications for surgery.

Ursula Sauer, Gittenberger-de Groot Ac, Max Geishauser,

PubMed

1989

69

Page 1